- Home
- JKHY vs BIRK Comparison
JKHY vs BIRK Comparison
Compare JKHY & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JKHY | BIRK |
|---|---|---|
| Founded | 1976 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.5B |
| IPO Year | 2000 | 2023 |
Fundamental Metrics
Financial Performance| Metric | JKHY | BIRK |
|---|---|---|
| Price | $153.78 | $41.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $197.25 | $61.43 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | ★ 19.31 | N/A |
| EPS | ★ 5.41 | N/A |
| Revenue | ★ $1,536,603,000.00 | N/A |
| Revenue This Year | $8.03 | $13.71 |
| Revenue Next Year | $6.39 | $14.30 |
| P/E Ratio | $27.83 | ★ $17.48 |
| Revenue Growth | ★ 7.37 | N/A |
| 52 Week Low | $121.04 | $31.33 |
| 52 Week High | $193.39 | $53.53 |
Technical Indicators
Market Signals| Indicator | JKHY | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 63.95 | 44.24 |
| Support Level | $153.74 | $40.98 |
| Resistance Level | $157.87 | $42.11 |
| Average True Range (ATR) | 4.49 | 1.82 |
| MACD | 0.09 | -0.48 |
| Stochastic Oscillator | 91.39 | 21.24 |
Price Performance
Historical ComparisonAbout JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, including electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.